Showing results (2791-2800 of 8,098) with videos related to
Sort By:
Pageof 810
Current Medicinal Chemistry|June 23, 2007
Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indicationsHeike Wulff, Aaron Kolski-Andreaco, Ananthakrishnan Sankaranarayanan, et al.Current Medicinal Chemistry|June 23, 2007
Dual action-based approaches to antibacterial agentsJohn B Bremner, Joseph I Ambrus, Siritron SamosornCurrent Medicinal Chemistry|June 23, 2007
Tumor necrosis factor-alpha monoclonal antibodies for Crohn's disease: tipping the balanceSilvio Danese, Nico Pagano, Erika Angelucci, et al.Current Medicinal Chemistry|June 23, 2007
Co-treatment with copper compounds dramatically decreases toxicities observed with cisplatin cancer therapy and the anticancer efficacy of some copper chelates supports the conclusion that copper chelate therapy may be markedly more effective and less toxic than cisplatin therapyJohn R J Sorenson, Grant W WangilaCurrent Medicinal Chemistry|June 23, 2007
Molecular probes for P2X7 receptor studiesHendra Gunosewoyo, Mark J Coster, Michael KassiouCurrent Medicinal Chemistry|June 23, 2007
Hypokalemia: a practical approach to diagnosis and its genetic basisShih-Hua Lin, Mitchell L HalperinCurrent Medicinal Chemistry|June 23, 2007
The road to advanced glycation end products: a mechanistic perspectiveS-J Cho, G Roman, F Yeboah, et al.Current Medicinal Chemistry|August 21, 2007
Nanochemistry-based immunotherapy for HIV-1F Lori, S A Calarota, J LisziewiczCurrent Medicinal Chemistry|August 19, 2007
Molecular target-guided tumor therapy with natural products derived from traditional Chinese medicineThomas Efferth, Yu-Jie Fu, Yuan-Gang Zu, et al.Current Medicinal Chemistry|August 19, 2007
Anti-arrhythmic properties of N-3 poly-unsaturated fatty acids (n-3 PUFA)Federico Lombardi, Paolo TerranovaPageof 810